- Home
- Products
- Customized FluoroAb™
- PTK7
- Anti-PTK7 MAb (Clone 2)-iFluor® 555 Succinimidyl Ester
Anti-PTK7 MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16444)
This product is comprised of an Humanized Anti-PTK7 IgG1-kappa (Clone 2) labeled with iFluor® 555 Succinimidyl Ester. iFluor® 555 Succinimidyl Ester is a Yellow-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- PTK7
- Overview
- Humanized Anti-PTK7 IgG1-kappa (Clone 2)
- Species Reactivity
- Human
- Name
- iFluor® 555 Succinimidyl Ester
- Color
- Yellow
- Excitation⁄Emission (nm)
- 557/570
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS16444. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-560 | Anti-PTK7-VC-auristatin ADC | VC (valine-citrulline) | Auristatin |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD3E MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS172)
- Anti-CD79B MAb (Clone 14)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13158)
- Anti-APP MAb (Clone 12)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6275)
- Anti-FOLH1 MAb (Clone 6)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8242)
- Anti-GUCY2C MAb (Clone 2)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6582)
- Anti-HBV surface antigen MAb (Clone 1)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2260)
- Anti-ITGA4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15496)
- Anti-MUC1 MAb (Clone 10)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14512)
- Anti-S1P MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4718)
- Anti-PDCD1 MAb (Clone 24)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9160)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.